Tymora Analytical Operations

• Anton Iliuk

  Chief technology officer

Sources: reporter.nih.gov

• National Institute on Aging

  R44, Validation and clinicaldevelopment of plasma EV protein biomarkers for minimally-invasive detection of Alzheimersdisease, R44AG063589, US$747.4k, 2019–2027, 10 Jul 2026

Sources: reporter.nih.gov

• Plasma proteomic Alzheimer's risk score: Biological age clock and pseudotime trajectory

  Consulting or advice, Board or leadership role, 1 Oct 2025

Sources: pubmed.ncbi.nlm.nih.gov